https://www.taxtmi.com/highlights?id=37828 Benefit of exemption - I.V. Fluids viz., Ofloxacin I.V. Infusion Revenue entertained a view that when the drugs manufactured by the respondents are administered intravenously, the same will not qualify for exemption as the said exemption is available only to I.V. Fluids used for Sugar, Electrolyte or Fluid replenishment - Contention of the revenue rejected - Benefit of N/N. 6/2002-CE allowed - AT en-us Mon, 05 Feb 2018 07:20:05 +0530 Mon, 05 Feb 2018 07:20:05 +0530 TaxTMI RSS Generator https://www.taxtmi.com/highlights?id=37828 Benefit of exemption - I.V. Fluids viz., Ofloxacin I.V. Infusion Revenue entertained a view that when the drugs manufactured by the respondents are administered intravenously, the same will not qualify for exemption as the said exemption is available only to I.V. Fluids used for Sugar, Electrolyte or Fluid replenishment - Contention of the revenue rejected - Benefit of N/N. 6/2002-CE allowed - AT Highlights Central Excise Mon, 05 Feb 2018 07:20:05 +0530 https://www.taxtmi.com/highlights?id=37828